Article
Sphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder
6 Sept 2021
Abstract excerpt
Genes encoding endocannabinoid and sphingolipid metabolism pathways were suggested to contribute to the genetic risk towards attention deficit hyperactivity disorder (ADHD). The present pilot study assessed plasma concentrations of candidate endocannabinoids, sphingolipids and ceramides in individuals with adult ADHD in comparison with healthy controls and patients with affective disorders. Targeted lipid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
